CytoMed Therapeutics Ltd Quarterly Liabilities in SGD from Q4 2021 to Q4 2023

Taxonomy & unit
ifrs-full: SGD and USD
Summary
CytoMed Therapeutics Ltd quarterly Liabilities history and growth rate from Q4 2021 to Q4 2023.
  • CytoMed Therapeutics Ltd Liabilities for the quarter ending December 31, 2023 was SGD1.12M, a 75.8% decline year-over-year.
Liabilities, Quarterly (SGD)
Liabilities, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.